Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and α-fetoprotein concentrations

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 1, 1999, Pages 207-215

  McLean, Mark ^a   Bisits, Andrew ^b   Davies, Joanne ^b   Walters, William ^b   Hackshaw, Allan ^b   De Voss, Kerry ^b   Smith, Roger ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b NONE

Author keywords

Corticotropin releasing hormone; Prematurity; Preterm delivery; Screening test; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CORTICOTROPIN RELEASING FACTOR;

ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK PREGNANCY; HUMAN; HUMAN TISSUE; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK ASSESSMENT; SCORING SYSTEM; SECOND TRIMESTER PREGNANCY;

EID: 0032864637     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70461-8     Document Type: Article

References (25)

1. 1. Knoches AM, Doyle LW. Long-term outcome of infants born preterm. Baillieres Clin Obstet Gynaecol 1993;7:633-51.
2. 2. Luke B, Bigger HR, Leurgans S, Sietsema D. The cost of prematurity: a case control study of twins vs singletons. Am J Public Health 1996;86:809-14.
3. 3. Lewitt EM, Baker LS, Corman H, Shiono PH. The direct cost of low birth weight. Future Child Child 1995;5:35-56.
4. 4. Geary M, Lamont RF. Prediction of preterm birth. In: Elder MG, Romero R, Lamont RF, editors. Preterm labor. New York: Churchill Livingstone; 1997. p. 51-63.
5. 5. King JF, Grant A, Keirse MJ, Chalmers I. Beta-mimetics in preterm labor: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988;95:211-22.
6. 6. Greasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980;55:685-92.
7. 7. McLean M, Walters W, Smith R. Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Sur 1993;48:209-25.
8. 8. Wolfe CD, Patel SP, Linton EA, Campbell EA, Anderson J, Dornhorst A, et al. Plasma corticotrophin releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol 1988;95:1003-6.
9. 9. Kurki T, Laatikainen T, Salminen-Lappalainen K, Ylikorkala O. Maternal plasma corticotrophin releasing hormone is elevated in preterm labour but unaffected by indomethacin or nylidrin. Br J Obstet Gynaecol 1991;98:685-91.
10. 10. Warren WB, Patrick SL, Goland RS. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1992;166:1198-207.
11. 11. McLean M, Bisits A, Davies JJ, Woods R, Lowry PJ, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995;1:460-3.
12. 12. Chan EC, Thomson M, Madsen G, Falconer J, Smith R. Differential processing of corticotrophin-releasing hormone by the human placenta and hypothalamus. Biochem Biophys Res Commun 1988;153:1229-35.
13. 13. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy [published erratum appears in BMJ 1988;297:1029], BMJ 1988;297:883-7.
14. 14. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy: report of UK collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977;1:1323-32.
15. 15. Burton BK, Sowers SG, Nelson LH. Maternal serum alpha-fetoprotein screening in North Carolina: experience with more than twelve thousand pregnancies. Am J Obstet Gynecol 1983;146:439-45.
16. 16. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-74.
17. 17. McGregor JA, Jackson GM, Lachelin GC, Goodwin TM, Artal R, Hastings C. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995;173:1337-42.
18. 18. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995;102:207-12.
19. 19. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICIID Maternal Fetal Medicine Units Network. Obstet Gynecol 1996;87:643-8.
20. 20. Thomas RL, Blakemore KJ. Evaluation of elevations in maternal serum alpha-fetoprotein: a review. Obstet Gynecol Surv 1990;45:269-83.
21. 21. Katz VL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv 1990;45:719-26.
22. 22. Brock DJ, Barron L, Jelen P, Watt M, Scrimgeour JB. Maternal serum alpha-fetoprotein measurement as an early indicator of low birth-weight. Lancet 1977;2:267-8.
23. 23. Riley SC, Walton JC, Herlick JM, Challis JR. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991;72:1001-7.
24. 24. Boyd PA. Why might maternal serum AFP be high in pregnancies in which the fetus is normally formed? Br J Obstet Gynaecol 1992;99:93-5.
25. 25. Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993;168:1223-30.